Refine
Has Fulltext
- yes (8)
Is part of the Bibliography
- yes (8)
Document Type
- Journal article (7)
- Review (1)
Language
- English (8)
Keywords
- cytotoxic T cells (2)
- ADP-ribosylation toxins (1)
- Activation induced cell death/AICD (1)
- Alpha therapy (1)
- Anergy (1)
- Apoptosis (1)
- Autoimmune diseases (1)
- Bone marrow transplantantation (1)
- C3 (1)
- CRAC (1)
- Ca2+ (1)
- Calcineurin (1)
- Expression (1)
- Factor receptor (1)
- Graft-versus-leukemia (1)
- Medizin (1)
- NF-κB (1)
- NFATc (1)
- NFATc1 (1)
- NFATc1/αA (1)
- Notch1 (1)
- OBF-1 OCA-B (1)
- OCT-1-deficient mice (1)
- Proliferation (1)
- Regulatory-cells (1)
- Rheumatoid arthritis (1)
- STIM1 (1)
- STIM2 (1)
- Suppression (1)
- T cell acute lymphoblastic leukemia (1)
- T-ALL (1)
- Tumor-necrosis-factor (1)
- actin filaments (1)
- anemia (1)
- bacterial toxins (1)
- botulinum C2 toxin (1)
- calcium (1)
- cellular uptake (1)
- channel (1)
- clostridium botulinum (1)
- coactivator OBF-1 (1)
- embryonic lethality (1)
- endothelial cells (1)
- functional characterization (1)
- gene expression (1)
- gene regulation (1)
- germinal center formation (1)
- immune cells (1)
- immunoglobulin promoters (1)
- infection (1)
- inflammation (1)
- interferon (1)
- lymphocyte activation (1)
- lymphocyte differentiation (1)
- macrophages (1)
- mammalian cells (1)
- membrane translocation (1)
- mitochondrial calcium uniporter (1)
- murine homolog (1)
- regulatory T cells (1)
- ribosyltransferase (1)
- signal transduction (1)
- suppressive capacity (1)
- translational research (1)
Institute
- Pathologisches Institut (5)
- Institut für Virologie und Immunbiologie (3)
- Institut für Systemimmunologie (2)
- Medizinische Klinik und Poliklinik II (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Experimentelle Biomedizin (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
Donor CD4\(^+\)Foxp3\(^+\) regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT allo-HCT]). Current clinical study protocols rely on the ex vivo expansion of donor T reg cells and their infusion in high numbers. In this study, we present a novel strategy for inhibiting GvHD that is based on the in vivo expansion of recipient T reg cells before allo-HCT, exploiting the crucial role of tumor necrosis factor receptor 2 (TNFR2) in T reg cell biology. Expanding radiation-resistant host T reg cells in recipient mice using a mouse TNFR2-selective agonist before allo-HCT significantly prolonged survival and reduced GvHD severity in a TNFR2-and T reg cell-dependent manner. The beneficial effects of transplanted T cells against leukemia cells and infectious pathogens remained unaffected. A corresponding human TNFR2-specific agonist expanded human T reg cells in vitro. These observations indicate the potential of our strategy to protect allo-HCT patients from acute GvHD by expanding T reg cells via selective TNFR2 activation in vivo.